BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 33317966)

  • 1. Brachytherapy-based radiotherapy is associated with improved survival for newly diagnosed metastatic cervical cancer.
    Ding L; Bi Z; Pan Z; Yu X; Zhao X; Bai S; Yao H; Liu Y
    Brachytherapy; 2021; 20(2):361-367. PubMed ID: 33317966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival.
    Quinn BA; Deng X; Colton A; Bandyopadhyay D; Carter JS; Fields EC
    Brachytherapy; 2019; 18(1):29-37. PubMed ID: 30361045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in definitive radiotherapy of uterine cervical cancer.
    Yalman D; Aras AB; Ozkök S; Duransoy A; Celik OK; Ozsaran Z; Haydaroğlu A
    Eur J Gynaecol Oncol; 2003; 24(3-4):309-14. PubMed ID: 12807246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brachytherapy Improves Survival in Stage III Endometrial Cancer With Cervical Involvement.
    Bingham B; Orton A; Boothe D; Stoddard G; Huang YJ; Gaffney DK; Poppe MM
    Int J Radiat Oncol Biol Phys; 2017 Apr; 97(5):1040-1050. PubMed ID: 28332987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging after external beam radiotherapy and concurrent chemotherapy for locally advanced cervical cancer helps to identify patients at risk of recurrence.
    Angeles MA; Baissas P; Leblanc E; Lusque A; Ferron G; Ducassou A; Martínez-Gómez C; Querleu D; Martinez A
    Int J Gynecol Cancer; 2019 Mar; 29(3):480-486. PubMed ID: 30712019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of radical doses of pelvic radiotherapy for primary tumor treatment in patients with newly diagnosed organ metastatic cervical cancer.
    Yin Z; Lou H; Tang H; Ni J; Zhou Q; Chen M
    Radiat Oncol; 2019 May; 14(1):82. PubMed ID: 31109371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of chemotherapy and radiotherapy in the adjuvant management of uterine carcinosarcoma: a population-based analysis.
    Ding L; Bi Z; Wu J; Zhu J; Yu Y; Yao HR; Liu YM
    Arch Gynecol Obstet; 2023 Mar; 307(3):891-901. PubMed ID: 35708782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined external and intracavitary irradiation in treatment of advanced cervical carcinomas: predictive factors for local tumor control and early recurrences.
    Sorbe B; Bohr L; Karlsson L; Bermark B
    Int J Oncol; 2010 Feb; 36(2):371-8. PubMed ID: 20043071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Californium-252 neutron brachytherapy combined with external pelvic radiotherapy plus concurrent chemotherapy for cervical cancer: a retrospective clinical study.
    Qian S; Ye L; Tian YH; Wang LG; Huang ZP; Li F; Hou B; Song N; Chen J; Liu Y; Liu X; Zhou T
    Chin J Cancer; 2017 Feb; 36(1):24. PubMed ID: 28245859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence--the University of Wisconsin experience.
    Petereit DG; Sarkaria JN; Potter DM; Schink JC
    Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1267-74. PubMed ID: 10613322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy.
    Perez CA; Grigsby PW; Castro-Vita H; Lockett MA
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1275-88. PubMed ID: 7635767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy Improves the Survival of Patients With Metastatic Cervical Cancer: A Propensity-Matched Analysis of SEER Database.
    Huang K; Jia M; Li P; Han J; Zhang R; Li Q; Qiao Y; Xu T; Ruan P; Song Q; Li Y; Fu Z
    Int J Gynecol Cancer; 2018 Sep; 28(7):1360-1368. PubMed ID: 30036221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of dose-effect relationship between DVH parameters and clinical prognosis of definitive radio(chemo)therapy combined with intracavitary/interstitial brachytherapy in patients with locally advanced cervical cancer: A single-center retrospective study.
    Zhang N; Tang Y; Guo X; Mao Z; Yang W; Cheng G
    Brachytherapy; 2020; 19(2):194-200. PubMed ID: 31791712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome and toxicity of radical radiotherapy or concurrent Chemoradiotherapy for elderly cervical cancer women.
    Wang W; Hou X; Yan J; Shen J; Lian X; Sun S; Liu Z; Meng Q; Wang D; Zhao M; Qiu J; Hu K; Zhang F
    BMC Cancer; 2017 Aug; 17(1):510. PubMed ID: 28764676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results for Stage IIIB cervical cancer patients receiving external beam radiotherapy combined with either HDR (252)Cf or HDR (60)Co intracavitary brachytherapy.
    Ulinskas K; Janulionis E; Valuckas KP; Samerdokiene V; Atkocius V; Rivard MJ
    Brachytherapy; 2016; 15(3):353-360. PubMed ID: 26996594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in outcome for cervical cancer patients treated with or without brachytherapy.
    Karlsson J; Dreifaldt AC; Mordhorst LB; Sorbe B
    Brachytherapy; 2017; 16(1):133-140. PubMed ID: 27836496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensity Modulated Radiation Therapy and Image-Guided Adapted Brachytherapy for Cervix Cancer.
    Lin AJ; Kidd E; Dehdashti F; Siegel BA; Mutic S; Thaker PH; Massad LS; Powell MA; Mutch DG; Markovina S; Schwarz J; Grigsby PW
    Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1088-1097. PubMed ID: 30445171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of marital status on receipt of brachytherapy and survival outcomes in locally advanced cervical cancer.
    Huynh-Le MP; Klapheke A; Cress R; Mell LK; Yashar CM; Einck JP; Mundt AJ; Mayadev JS
    Brachytherapy; 2019; 18(5):612-619. PubMed ID: 31153760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brachytherapy should not be omitted when treating locally advanced neuroendocrine cervical cancer with definitive chemoradiation therapy.
    Robin TP; Amini A; Schefter TE; Behbakht K; Fisher CM
    Brachytherapy; 2016; 15(6):845-850. PubMed ID: 27720204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brachytherapy Is Associated With Improved Survival in Inoperable Stage I Endometrial Adenocarcinoma: A Population-Based Analysis.
    Acharya S; Perkins SM; DeWees T; Fischer-Valuck BW; Mutch DG; Powell MA; Schwarz JK; Grigsby PW
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):649-57. PubMed ID: 26461007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.